Showing results (141-150 of 279) with videos related to
Sort By:
Pageof 28
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Schedule-dependent antagonism of paclitaxel and cisplatin in human gastric and ovarian carcinoma cell lines in vitroU Vanhoefer, A Harstrick, H Wilke, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1988
Phase I study of pirarubicinA A Miller, M E Scheulen, U R Kleeberg, et al.Oncology (Williston Park, N.Y.)|August 12, 1999
Paclitaxel and UFT plus oral calcium folinate in pretreated metastatic breast cancerU Klaassen, D Borquez, S Lang, et al.Journal of Cancer Research and Clinical Oncology|April 24, 2001
High-dose chemotherapy with peripheral blood stem cell transplantation for patients with advanced ovarian cancerP Bojko, M E Scheulen, R Hilger, et al.Cancer Treatment Reports|April 1, 1980
Sequential combination chemotherapy with vinblastine-bleomycin and doxorubicin-cis-dichlorodiammineplatinum(II) in disseminated nonseminomatous testicular cancerM E Scheulen, S Seeber, R B Schilcher, et al.Cancer Treatment Reviews|September 1, 1983
Ifosfamide in combination chemotherapy for sarcomas and testicular carcinomasN Niederle, M E Scheulen, M Cremer, et al.Leukemia Research|April 28, 2000
Analysis of thrombopoietin receptor (c-mpl) mRNA expression in de novo acute myeloid leukemiaJ K Schröder, S Kolkenbrock, J Tins, et al.Breast Cancer Research and Treatment|January 5, 2002
Evaluation of different methods for the detection of minimal residual disease in blood and bone marrow of patients with primary breast cancer: importance for clinical use?S Kasimir-Bauer, C Oberhoff, K Sliwinska, et al.Leukemia Research|June 1, 1993
Analysis of the p53 gene in patients with isochromosome 17q and Ph1-positive or -negative myeloid leukemiaJ Schütte, B Opalka, R Becher, et al.Journal of Interferon Research|October 1, 1992
Opposite sensitivity to the antiproliferative action of interferon-alpha and granulocyte-macrophage colony-stimulating factor in monoblastic U937 cellsO Kloke, T Moritz, G Kummer, et al.Pageof 28